Instructions for Authors

JDRR publishes the following article types. Requirements depend on the type; items such as hypotheses, Methods and Results sections, statistics and checklists apply where applicable.

• Original Research
• Review (including mini-review)
• Systematic Review and Meta-Analysis
• Methods and Protocols
• Short Communication (including technical note)
• Data Note
• Case Report
• Perspective or Commentary
• Letter

• Original Research: new experimental, computational or clinical findings, with Introduction, Methods, Results and Discussion.
• Review: a balanced synthesis of a defined topic, including mini-reviews; a Methods statement describing how the literature was identified is encouraged.
• Systematic Review and Meta-Analysis: a registered or pre-specified protocol where applicable, search strategy, selection criteria and PRISMA reporting.
• Methods and Protocols: a method or protocol described in enough detail to be reproduced, with validation data and the reagents and equipment used.
• Short Communication: a concise report of a finding, or a technical note on a method, instrument or software tool.
• Data Note: a description of a dataset, how it was generated and where it is deposited.
• Case Report: a case or case series of genetic or molecular interest, with patient consent.
• Perspective or Commentary: a reasoned view on a development in the field, including opinion and hypothesis pieces supported by evidence.
• Letter: a short, evidence-based response to an article published in the journal or a point of general interest.

There are no fixed length limits for any article type; manuscripts should be concise and proportionate to their content.

• Title page: title, authors with affiliations and ORCID iDs where available, corresponding author, and a running title.
• Abstract: a structured abstract (background, methods, results, conclusions) for Original Research; a concise unstructured abstract for other types. Cite no references in the abstract.
• Keywords: a short list of terms that help readers find the article.
• Main text: Introduction, Methods, Results, Discussion and Conclusions for research articles; a logical heading structure for other types.
• Back matter: author contributions (CRediT), funding, conflicts of interest, ethics statements, data availability, acknowledgments and AI-use disclosure.

Manuscripts are submitted in Word or LaTeX-compatible format. Use standard units, define abbreviations at first use and write in clear English; language-editing services are available to authors on request and do not influence editorial decisions.

• Use official gene and protein symbols and name organisms, strains and cell lines with their source. Describe sequence variants using HGVS nomenclature.
• List primers, oligonucleotides, guide RNAs and probes with their sequences in a table or supplementary file. Identify antibodies, plasmids and cell lines with catalog numbers or repository identifiers.
• Deposit sequencing and expression data in GenBank, ENA, DDBJ, SRA or GEO, and structures in the Protein Data Bank or comparable resources, and give accession numbers in the manuscript.
• Report quantitative PCR in line with MIQE, and sequencing and functional genomics experiments in line with MINSEQE, where applicable.
• Provide original, uncropped images of gels and blots as supplementary files, and state any image processing.

Follow the guideline that matches the study design and include the completed checklist where one exists.

Ethics approval and consent follow the Editorial Policies: approval is reported where applicable, with informed consent or a waiver documented by the ethics committee, where applicable.

Interventional clinical trials must be registered in an accepted public trial registry at or before the first participant provides consent for enrollment. The registry name, registration number, and registration date must be reported in the manuscript.

• Submit figures as TIFF, PNG, JPEG, PDF or EPS files at a resolution of at least 300 dpi, with legends in the manuscript.
• Prepare tables as editable text, not images, with a title and notes.
• Supplementary files (data tables, extended methods, raw images, code) are cited in the text and provided in open formats.
• Reused or adapted material (figures, tables or text from other sources) is credited to its source. Permission from the copyright holder, supplied with the submission, is required unless the material's license already permits the reuse (for example, CC BY with attribution). See Copyright and License and Data Archiving and Permissions.

Describe statistical methods and software, the unit of analysis, the number of independent replicates, and how multiple comparisons were handled. Report effect sizes with measures of uncertainty rather than p values alone, and state exclusions and how they were decided.

Cite references by number in order of appearance. Give a DOI where one exists. Formats:

• Article: Author AA, Author BB. Title of article. Journal Abbreviation. Year;Volume(Issue):Pages. doi:10.xxxx/xxxxx
• Book: Author AA. Title of book. Edition. City: Publisher; Year.
• Webpage: Organization. Title of page. URL (accessed Day Month Year).
• Dataset: Author AA. Title of dataset. Repository; Year. Accession or DOI.
• Preprint: Author AA. Title. Preprint server; Year. doi:10.xxxx/xxxxx
• Trial registration: Registry. Title. Registration number; Year. URL

Single-blind by default; double-blind review is available on request.

For double-blind review, remove author names, affiliations, acknowledgments, funding details, institution names, and other identifying information from the reviewer manuscript. Provide identifying information separately in the title-page file or submission form.

Every manuscript includes statements on funding, competing interests, author contributions and data availability. Every empirical research manuscript must include a data-availability statement.

Disclose any use of generative AI or AI-assisted tools in preparing the manuscript, naming the tool and its purpose. AI tools are not listed as authors.

1. ManuscriptZone is the primary route: Open Access Pub's online submission and tracking system.
2. Manuscript submission form is the alternative route: a one-page form that sends the manuscript to the JDRR editorial office.
3. Editorial email is the assisted route: write to info@openaccesspub.org for help with submitting.

• The manuscript is in scope and suited to one of the article types above.
• Ethics approval, consent and trial registration are reported where applicable.
• Data, code and sequence accession numbers are cited, and a data-availability statement is included.
• The reporting checklist for the study design is completed.
• Funding, conflicts of interest, author contributions and any AI use are declared.
• Figures, tables and supplementary files are complete and legible.
• The manuscript is submitted by one route only.

The article processing charge depends on the article type and is payable only after acceptance; withdrawal after submission is subject to the journal's withdrawal policy. See Article Processing Charges. Fee-relief inquiries are considered case by case; contact the editorial office before or at submission.